Ret Proto-Oncogene anticorps (N-Term)

N° du produit ABIN544339

Détail du produit anti-Ret Proto-Oncogene anticorps

Antigène: Ret Proto-Oncogene (RET)

Épitope: N-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Ret Proto-Oncogene est non-conjugé

Application: Western Blotting (WB), Flow Cytometry (FACS)

Fonction: Rabbit polyclonal antibody raised against synthetic peptide of RET.

Réactivité croisée: Humain

Immunogène: A synthetic peptide (conjugated with KLH) corresponding to N-terminus of human RET.

Information d'application

Indications d'application: Flow Cytometry (1:10-50)
Western Blot (1:1000)
The optimal working dilution should be determined by the end user.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: In PBS (0.09 % sodium azide)

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Références pour anticorps anti-Ret Proto-Oncogene (ABIN544339)

DAlessio, Califano, Incoronato, Santelli, Florio, Schettini, Carlomagno, Cerchia, de Franciscis: "The tyrosine phosphatase Shp-2 mediates intracellular signaling initiated by Ret mutants." dans: Endocrinology, Vol. 144, Issue 10, pp. 4298-305, (2003) (PubMed).

McWhinney, Boru, Binkley, Peczkowska, Januszewicz, Neumann, Eng: "Intronic single nucleotide polymorphisms in the RET protooncogene are associated with a subset of apparently sporadic pheochromocytoma and may modulate age of onset." dans: The Journal of clinical endocrinology and metabolism, Vol. 88, Issue 10, pp. 4911-6, (2003) (PubMed).

Da Silva, Maciel, Da Silva, Toledo, De Carvalho, Cerutti: "A novel germ-line point mutation in RET exon 8 (Gly(533)Cys) in a large kindred with familial medullary thyroid carcinoma." dans: The Journal of clinical endocrinology and metabolism, Vol. 88, Issue 11, pp. 5438-43, (2003) (PubMed).

Détails sur Ret Proto-Oncogene

Antigène: Ret Proto-Oncogene (RET)

Autre désignation: RET (RET Produits)

Synonymes: anticorps c-ret, anticorps cret, anticorps etID315074.13, anticorps ret1, anticorps wu:fd13h01, anticorps X-ret, anticorps ret-A, anticorps xret, anticorps RET, anticorps MTC1, anticorps CDHF12, anticorps CDHR16, anticorps HSCR1, anticorps MEN2A, anticorps MEN2B, anticorps PTC, anticorps RET-ELE1, anticorps RET51, anticorps RET9, anticorps c-Ret, anticorps ret proto-oncogene receptor tyrosine kinase, anticorps ret proto-oncogene S homeolog, anticorps ret proto-oncogene, anticorps ret, anticorps ret.S, anticorps RET, anticorps Ret

ID gène: 5979

Pathways: Signalisation RTK, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation